Il y a eu 50 transactions d'initiés récentes enregistrées pour Larimar Therapeutics, Inc. (LRMR), dont 47 achats et 0 ventes. Le total des achats d'initiés s'élève à $34.99M et le total des ventes d'initiés à RSU Award.
Les initiés notables ayant une activité récente comprennent Sherman Jeffrey W, Thomas Frank E, Flynn James E. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — LRMR
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-02-27 |
Sherman Jeffrey W |
Director |
Achat Informatif |
5,000 |
$5.00 |
$25K |
5,000 |
| 2026-02-27 |
Thomas Frank E |
Director |
Achat Informatif |
5,000 |
$5.00 |
$25K |
7,000 |
| 2026-02-27 |
Flynn James E |
10 Percent Owner, Other: * Director By Deputization |
Achat Informatif |
2,000,000 |
$5.00 |
$10M |
6,207,982 |
| 2026-02-27 |
Hamilton Thomas Edward |
Director |
Achat Informatif |
100,000 |
$5.00 |
$500K |
664,798 |
| 2026-01-26 |
Celano Michael |
Chief Financial Officer |
Attribution de RSU |
37,604 |
- |
- |
215,785 |
| 2026-01-26 |
Ben-maimon Carole |
President and CEO |
Attribution de RSU |
100,100 |
- |
- |
368,276 |
| 2026-01-26 |
Clayton Russell |
Chief Medical Officer |
Attribution de RSU |
25,637 |
- |
- |
71,443 |
| 2026-01-26 |
Shankar Gopi |
Chief Development Officer |
Attribution de RSU |
25,637 |
- |
- |
76,443 |
| 2025-07-31 |
Flynn James E |
10 Percent Owner, Other: * Director By Deputization |
Achat Informatif |
2,599,932 |
$3.20 |
$8.32M |
7,321,129 |
| 2025-05-13 |
Leff Jonathan S |
Director |
Attribution de RSU |
19,000 |
$1.88 |
$35.63K |
19,000 |
| 2025-05-13 |
Sherman Jeffrey W |
Director |
Attribution de RSU |
19,000 |
$1.88 |
$35.63K |
19,000 |
| 2025-05-13 |
Thomas Frank E |
Director |
Attribution de RSU |
19,000 |
$1.88 |
$35.63K |
19,000 |
| 2025-05-13 |
Truitt Joseph |
Director |
Attribution de RSU |
19,000 |
$1.88 |
$35.63K |
19,000 |
| 2025-05-13 |
Hamilton Thomas Edward |
Director |
Attribution de RSU |
19,000 |
$1.88 |
$35.63K |
19,000 |
| 2025-05-13 |
Flynn James E |
10 Percent Owner, Other: * Director By Deputization |
Attribution de RSU |
19,000 |
$1.88 |
$35.63K |
19,000 |
| 2025-01-22 |
Celano Michael |
Chief Financial Officer |
Attribution de RSU |
34,185 |
- |
- |
178,181 |
| 2025-01-22 |
Ben-maimon Carole |
President and CEO |
Attribution de RSU |
91,000 |
- |
- |
387,208 |
| 2025-01-22 |
Clayton Russell |
Chief Medical Officer |
Attribution de RSU |
23,306 |
- |
- |
45,806 |
| 2025-01-22 |
Shankar Gopi |
Chief Development Officer |
Attribution de RSU |
23,306 |
- |
- |
50,806 |
| 2024-05-29 |
Leff Jonathan S |
Director |
Attribution de RSU |
19,000 |
$7.07 |
$134.33K |
19,000 |
| 2024-05-29 |
Sherman Jeffrey W |
Director |
Attribution de RSU |
19,000 |
$7.07 |
$134.33K |
19,000 |
| 2024-05-29 |
Thomas Frank E |
Director |
Attribution de RSU |
19,000 |
$7.07 |
$134.33K |
19,000 |
| 2024-05-29 |
Truitt Joseph |
Director |
Attribution de RSU |
19,000 |
$7.07 |
$134.33K |
19,000 |
| 2024-05-29 |
Hamilton Thomas Edward |
Director |
Attribution de RSU |
19,000 |
$7.07 |
$134.33K |
19,000 |
| 2024-05-29 |
Flynn James E |
10 Percent Owner, Other: * Director By Deputization |
Attribution de RSU |
19,000 |
$7.07 |
$134.33K |
19,000 |
| 2024-02-16 |
Flynn James E |
10 Percent Owner, Other: * Director By Deputization |
Achat Informatif |
1,430,205 |
$8.74 |
$12.5M |
4,207,982 |
| 2024-02-16 |
Hamilton Thomas Edward |
Director |
Achat Informatif |
57,208 |
$8.74 |
$500K |
564,798 |
| 2024-02-14 |
Thomas Frank E |
Director |
Achat Informatif |
2,000 |
$11.00 |
$22K |
2,000 |
| 2024-01-17 |
Celano Michael |
Chief Financial Officer |
Attribution de RSU |
31,250 |
- |
- |
143,996 |
| 2024-01-17 |
Ben-maimon Carole |
President and CEO |
Attribution de RSU |
66,125 |
- |
- |
332,954 |
| 2024-01-17 |
Clayton Russell |
Chief Medical Officer |
Attribution de RSU |
22,500 |
- |
- |
22,500 |
| 2024-01-17 |
Shankar Gopi |
Chief Development Officer |
Attribution de RSU |
22,500 |
- |
- |
27,500 |
| 2023-12-07 |
Shankar Gopi |
Chief Development Officer |
Achat Informatif |
5,000 |
$3.73 |
$18.66K |
5,000 |
| 2023-10-03 |
Sherman Jeffrey W |
Director |
Inconnu |
- |
- |
- |
- |
| 2023-10-03 |
Sherman Jeffrey W |
Director |
Attribution de RSU |
16,600 |
$3.56 |
$59.01K |
16,600 |
| 2023-07-17 |
Clayton Russell |
Officer |
Inconnu |
- |
- |
- |
- |
| 2023-07-17 |
Clayton Russell |
Chief Medical Officer |
Attribution de RSU |
180,000 |
$3.22 |
$579.6K |
180,000 |
| 2023-05-17 |
Celano Michael |
Chief Financial Officer |
Achat Informatif |
5,000 |
$3.73 |
$18.63K |
112,746 |
| 2023-05-17 |
Truitt Joseph |
Director |
Achat Informatif |
2,750 |
$3.73 |
$10.26K |
2,750 |
| 2023-05-17 |
Ben-maimon Carole |
President and CEO |
Achat Informatif |
5,000 |
$3.71 |
$18.53K |
266,829 |
| 2023-05-09 |
Leff Jonathan S |
Director |
Attribution de RSU |
8,300 |
$5.09 |
$42.25K |
8,300 |
| 2023-05-09 |
Thomas Frank E |
Director |
Attribution de RSU |
8,300 |
$5.09 |
$42.25K |
8,300 |
| 2023-05-09 |
Flynn James E |
10 Percent Owner |
Attribution de RSU |
8,300 |
$5.09 |
$42.25K |
8,300 |
| 2023-05-09 |
Truitt Joseph |
Director |
Attribution de RSU |
8,300 |
$5.09 |
$42.25K |
8,300 |
| 2023-05-09 |
Hamilton Thomas Edward |
Director |
Attribution de RSU |
8,300 |
$5.09 |
$42.25K |
8,300 |
| 2023-02-07 |
Shankar Gopi |
Officer |
Inconnu |
- |
- |
- |
- |
| 2023-02-07 |
Shankar Gopi |
Chief Development Officer |
Attribution de RSU |
180,000 |
$5.88 |
$1.06M |
180,000 |
| 2023-01-31 |
Celano Michael |
Chief Financial Officer |
Attribution de RSU |
76,000 |
- |
- |
107,746 |
| 2023-01-31 |
Ben-maimon Carole |
President and CEO |
Attribution de RSU |
205,000 |
- |
- |
261,829 |
| 2022-09-16 |
Celano Michael |
Chief Financial Officer |
Achat Informatif |
31,746 |
$3.15 |
$100K |
31,746 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi